Previous Close | 24.52 |
Open | 24.52 |
Bid | 23.64 x 400 |
Ask | 23.83 x 100 |
Day's Range | 23.52 - 24.58 |
52 Week Range | 20.84 - 34.28 |
Volume | |
Avg. Volume | 1,095,196 |
Market Cap | 2.466B |
Beta (5Y Monthly) | 0.48 |
PE Ratio (TTM) | 22.56 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Corcept Therapeutics ( NASDAQ:CORT ) First Quarter 2024 Results Key Financial Results Revenue: US$146.8m (up 39% from...
Corcept (CORT) beats on both earnings and sales in the first quarter of 2024. The company increases revenue guidance for 2024.
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2024 Earnings Call Transcript May 1, 2024 Corcept Therapeutics Incorporated beats earnings expectations. Reported EPS is $0.2503, expectations were $0.21. Corcept Therapeutics Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank […]